Group 1: Company Development and Strategy - The company started with trade and gradually transitioned to manufacturing, focusing on R&D and establishing an integrated manufacturing base [2] - Since 2010, the company has concentrated on core generic drug R&D, enhancing manufacturing standards through independent innovation and establishing a new drug creation system [2] - The company has set up overseas branches to expand its market presence, focusing on high-value compound production and global marketing [2] Group 2: Product Orders and Pricing - Orders are generally determined quarterly, with adjustments based on market conditions [3] - Pricing is based on market prices, with adjustments made during significant price fluctuations [3] - The company employs different pricing strategies for major clients, balancing cost and market prices [3] Group 3: International Market and Registration - The company has invested approximately €14 million in obtaining registration certificates for products in Europe, with plans to expand in the US and Brazil [3] - Sales primarily occur in the B2B sector, with transactions in USD, EUR, or RMB, and the company collaborates with partners for overseas sales [3] Group 4: R&D and Innovation - The company is developing innovative drugs with specific pricing strategies based on market analysis and profit considerations [4] - The creation of compounds involves both internal selection and collaboration with academic institutions and multinational companies [4] Group 5: Product Expansion and Market Strategy - The company prioritizes new products that complement existing fungicides and herbicides, considering market space and technical barriers [4] - The global market for the product Pyraclostrobin reached $1.328 billion in 2023, with expected growth in domestic usage by 2025 [4] - The company is a major producer of the fungicide Azoxystrobin and aims to increase market share as recognition of the product grows [4] Group 6: Risk Management - Key risks include fluctuations in global agricultural product prices, trade policy uncertainties, and foreign exchange risks [5] - The company manages risks through inventory optimization, sales strategy adjustments, and financial hedging tools [5]

Group 1: Core Products and Market Impact - The company's key product, Bacillus thuringiensis (百菌清), maintains a global market share of approximately 60% with an annual growth rate of 3%-5% [3] - The star product, Pyraclostrobin (嘧菌酯), accounts for about 20% of the global market share this year [3] - The herbicide 2,4-D remains profitable despite market price fluctuations due to strategic partnerships with raw material suppliers [3] Group 2: Market Trends and Strategic Adjustments - Overall, the core products are minimally affected by U.S. tariffs, although anti-dumping measures impact some products [3] - Increased procurement from Latin America, particularly Brazil, is noted as a key market [3] - The company is cautious about the market opportunities for alternative products like Glyphosate, with no current plans for related investments [3] Group 3: Production and Capacity Plans - The company plans to adjust and restart the production of the Thiamethoxam project in the second half of the year, with a focus on the European market [3] - The company has invested €14 million in 2019 to acquire registration for Thiamethoxam and is collaborating with several international agrochemical companies [3] - The company is evaluating capacity expansion to match the significant increase in export volume this year compared to the previous two years [4] Group 4: Risk Management and Financial Strategies - In Brazil, all transactions are conducted in USD to mitigate risks associated with local currency fluctuations [4] - The company is implementing measures to manage exchange rate risks, including financial tools to lock in exchange rates [4] - Ongoing discussions with major clients regarding contract details are expected to align with their annual ordering cycles [4] Group 5: Future Development and Investment - The company is advancing overseas investment and financing plans in response to the growing demand for multi-component pesticides in Latin America and the U.S. [4] - Domestic projects will be prioritized based on capacity planning, while the Egypt project is a key focus for overseas expansion [4] - The strategy for expanding new pesticide categories will prioritize products that complement existing fungicides and herbicides [4]

2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 南通泰禾化工股份有限公司（以下简称"公司"）2024 年年度权益分派方案已 获 2025 年 5 月 21 日召开的 2024 年年度股东会审议通过，现将权益分派事宜公告 如下： 证券代码：301665 证券简称：泰禾股份 公告编号：2025-027 南通泰禾化工股份有限公司 一、股东会审议通过利润分配方案情况 1、公司于 2025 年 5 月 21 日召开了 2024 年年度股东会，审议通过了《关于 公司 2024 年度利润分配预案的议案》，分派方案的具体内容为：以公司现有总股 本 450,000,000 股为基数，向全体股东每 10 股派发现金股利人民币 4 元（含税）， 共派发现金股利人民币 180,000,000 元(含税)，不送红股，不以资本公积金转增股 本，剩余未分配利润结转至以后年度分配。 在利润分配预案披露日至实施权益分派股权登记日期间，如公司总股本发生 变动，则以实施分配方案时股权登记日的总股本为基数，公司将按照现金分红分 配比例固定不变的原则对现金分红总额进行 ...

Group 1: Product Performance - The overall revenue for fungicides in 2024 is 1.465 billion CNY, representing a year-on-year growth of 23.39% [2] - The overall revenue for herbicides in 2024 is 1.929 billion CNY, with a year-on-year growth of 2.64% [3] - The overall revenue for functional chemicals in 2024 is 474 million CNY, showing a year-on-year decline of 6.30% [3] Group 2: Q1 2025 Financial Performance - In Q1 2025, the company achieved a revenue of 1.033 billion CNY, reflecting a year-on-year increase of 18.50% [4] - The net profit attributable to shareholders in Q1 2025 is 78.53 million CNY, marking a year-on-year growth of 50.94% [4] - The net profit excluding non-recurring items in Q1 2025 is 75.45 million CNY, with a year-on-year increase of 59.79% [4] Group 3: Product Development and Market Trends - The newly developed pesticide, cyhalofop-butyl, received export registration in July 2024 and is expected to obtain domestic registration by the end of the year [5] - The company has signed a cooperation agreement with Syngenta and a global strategic partnership with UPL for the development and commercialization of cyhalofop-butyl [5] - The market for pesticides is currently stable, with sufficient product demand, and the company plans to establish overseas manufacturing bases to meet future demand [6][7] Group 4: Profitability and Market Strategy - The decline in herbicide gross margin is attributed to overall market price decreases [7] - The company considers product growth potential, competitiveness, customer demand, and market share when developing new products [7] - Environmental policies have minimal impact on the company's products, focusing mainly on emission standards and management [7] Group 5: R&D and Future Planning - The company has over 10 years of experience in new pesticide development, establishing a comprehensive R&D system with advanced facilities [8] - Future R&D will focus on resistance and mechanism-related directions, although specific details are not disclosed [8] - The company emphasizes quality over blind expansion, prioritizing products that align with its core technologies and customer base [8]

证券代码：301665 证券简称：泰禾股份 公告编号：2025-026 南通泰禾化工股份有限公司 2024年年度股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次会议不存在否决议案的情形； 2、本次股东会不涉及变更以往股东会决议的情形。 一、会议召开和出席情况 （一）股东会召开时间 1、现场会议时间：2025年5月21日（星期三）下午15:00 2、网络投票时间：（1）通过深圳证券交易所交易系统进行网络投票的具 体时间为：2025年5月21日9:15-9:25，9:30—11:30，13:00—15:00；（2）通过深 圳证券交易所互联网投票系统投票的具体时间为：2025年5月21日上午9:15—下 午15:00期间的任意时间。 3、股东会现场会议召开地点：上海市松江区九亭镇顺庆路650号2幢101室。 4、股东会召开方式：本次股东会采取现场投票与网络投票相结合的方式召 开。 5、股东会的召集人和主持人：本次股东会由公司董事会召集，董事长田晓 宏先生主持。 6、本次股东会的召开符合有关法律、行政法规、部门规章、规范性文件、 深 ...

北京市汉坤律师事务所 关于 南通泰禾化工股份有限公司 2024 年年度股东会 的 中国北京市东长安街 1 号东方广场 C1 座 9 层 100738 电话：(86 10) 8525 5500；传真：(86 10) 8525 5511 / 8525 5522 北京 上海 深圳 香港 海口 武汉 新加坡 纽约 www.hankunlaw.com 法律意见书 汉坤（证）字[2025]第 35778-2-O-1 号 关于南通泰禾化工股份有限公司 北京市汉坤律师事务所 2024 年年度股东会的法律意见书 北京市汉坤律师事务所 关于南通泰禾化工股份有限公司 2024 年年度股东会的 法律意见书 汉坤（证）字[2025]第 35778-2-O-1 号 致：南通泰禾化工股份有限公司 南通泰禾化工股份有限公司（以下简称"公司"）2024 年年度股东会（以下简 称"本次股东会"）采取现场投票与网络投票相结合的方式，现场会议于 2025 年 5 月 21 日在上海市松江区九亭镇顺庆路 650 号 2 幢 101 室召开。北京市汉坤律师事 务所（以下简称"本所"）接受公司聘任，指派本所律师参加并对本次股东会现场会 议进行见证，并根据 ...

Key Points - The article highlights various significant announcements from companies, including revenue growth, investment projects, and share buybacks [1][2] Company Announcements - Baili Electric's revenue from related businesses in 2024 will account for less than 1% of the company's total revenue [1] - Taihe Co., Ltd. plans to invest up to $150 million in a pesticide and functional chemicals project in Egypt [1] - Huakang Clean is expected to win a bid for the renovation of the second inpatient building at West China Hospital of Sichuan University [1] - YTO Express reported a revenue of 5.755 billion yuan from express products in April, a year-on-year increase of 16.32% [1] - Shentong Express reported a revenue of 4.118 billion yuan from express services in April, a year-on-year increase of 16.39% [1] - Kangping Technology plans to acquire 100% equity of Souluke Electronics for 198 million yuan [1] - Hexing Packaging intends to repurchase shares worth between 50 million to 100 million yuan [1] - Guangxi Media's controlling shareholder and its concerted parties plan to reduce their holdings by no more than 1% [1] - Huading Co., Ltd. plans to reduce its holdings by no more than 3% [1] - Jingu Co., Ltd. received a notification from a leading global new energy vehicle company [1] - Wanrun New Energy signed a business cooperation agreement with CATL, expecting a total supply volume of approximately 1.3231 million tons [1][2] Investment Projects - Huaheng Biological plans to invest 320 million yuan in an "AI Precision Fermentation and Protein Engineering Shared Demonstration Project" [1] Share Buybacks - Kesi Technology plans to repurchase shares worth between 30 million to 50 million yuan [1] - Zhaoxun Media intends to repurchase 1.66% to 3.33% of its shares [2]

Core Viewpoint - The article summarizes significant announcements from various listed companies in the Shanghai and Shenzhen stock markets, providing insights for investors on recent corporate actions and developments. Group 1: Corporate Announcements - Kweichow Moutai's shareholders approved a profit distribution plan for 2024, proposing a cash dividend of 276.24 yuan per 10 shares, totaling 34.672 billion yuan [3] - Weir Shares plans to change its name to "Haowei Group" and its stock abbreviation to "Haowei Group," pending shareholder approval [4] - Weili intends to transfer 100% equity of its subsidiary Dunhua Zhongneng to Chengfa Environment for a total consideration of approximately 323 million yuan [6] - Wanrun New Energy signed a business cooperation agreement with CATL to supply lithium iron phosphate products, with an estimated total supply of about 1.3231 million tons from 2025 to 2030 [7] - Shouhua Gas plans to purchase bauxite resources through market means, with a financing application of up to 2 billion yuan [8] Group 2: Regulatory and Compliance - Gao Neng Environment received an administrative regulatory decision from the Beijing Securities Regulatory Bureau due to insufficient impairment testing and inaccurate disclosures [9] - ST Shilong applied to revoke its other risk warning status, indicating compliance with relevant regulations [14] Group 3: Mergers and Acquisitions - Huixin Electronics plans to acquire 67.91% of Baode Computer through a combination of cash and stock issuance, enhancing its position in the IT infrastructure sector [19] - Kangping Technology intends to acquire 100% of Sulu Electronics for 198 million yuan to expand its electric tools business [23] - Xinjiang Haoyuan plans to change its name to "Wanqing Energy" to better reflect its business structure [26] Group 4: Financing and Investments - Shanghai Xinyang plans to invest 30 million yuan in the establishment of the Qixin Fund, focusing on high-tech sectors [12] - Taihe Co. intends to invest up to 150 million USD (approximately 1.082 billion yuan) in a pesticide and functional chemicals project in Egypt [28] Group 5: Strategic Partnerships and Contracts - Dongzhu Ecology signed a 3.5 billion yuan EPC contract for land consolidation in Laos [30] - Youa Co. signed a strategic cooperation framework agreement with Changsha Guokong Capital and Tsinghua Electronics Institute to promote the semiconductor industry [32] Group 6: Shareholder Actions - Wanfeng Co. plans to reduce its stake by up to 1.75% through block trading [35] - Tuoershi's controlling shareholder intends to reduce its stake by up to 2% [36]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 南通泰禾化工股份有限公司（以下简称"公司"）第三届董事会第十八次会议 通知已于 2025 年 5 月 13 日通过邮件方式送达。会议于 2025 年 5 月 19 日以现 场结合通讯方式在公司会议室召开。本次会议应出席董事 9 名，实际出席董事 9 名（其中通讯方式出席董事 4 名）。会议由董事长田晓宏先生召集并主持，公司 监事列席了会议。本次会议的召开和表决程序符合《中华人民共和国公司法》等 法律、法规、规范性文件和《公司章程》的有关规定，会议合法、有效。 二、董事会会议审议情况 全体董事经过认真审议和表决，形成如下决议： 证券代码：301665 证券简称：泰禾股份 公告编号：2025-023 南通泰禾化工股份有限公司 第三届董事会第十八次会议决议公告 三、备查文件 1、第三届董事会第十八次会议决议； 2、第三届董事会战略委员会 2025 年第一次会议决议。 特此公告。 南通泰禾化工股份有限公司 董事会 2025 年 5 月 19 日 1、审议通过了《关于对外投资建设农药及功能化学品项目 ...

证券代码：301665 证券简称：泰禾股份 公告编号：2025-025 为开拓海外市场，满足公司未来全球业务发展需要，积极响应国家"一带一 路"政策，南通泰禾化工股份有限公司（以下简称"公司"）于2025年5月19日召 开第三届董事会第十八次会议、第三届监事会第十二次会议，分别审议通过了 《关于对外投资建设农药及功能化学品项目的议案》，同意公司以自有及自筹 资金不超过1.5亿美元（按照1美元兑换人民币7.2150元汇率折算约为10.8225亿 元）在埃及建设农药及功能化学品项目。 根据《深圳证券交易所创业板股票上市规则》《公司章程》等相关规定，本 次投资事项在董事会的审批权限范围内，无需提交公司股东会审议批准，同时 提请董事会授权董事长或其指定人员具体负责办理此项投资的所有后续事项， 包括但不限于决定投资项目的具体实施方式、实施主体、签署相关协议、办理 有关投资备案或审批手续等。 本次对外投资不构成关联交易，亦不构成《上市公司重大资产重组管理办法》 规定的重大资产重组。 二、投资标的的基本情况 南通泰禾化工股份有限公司 关于对外投资建设农药及功能化学品项目的公告 本公司及董事会全体成员保证信息披露内容的真实、 ...